Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA)

84 filings reported holding CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q3 2024.
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 13.5M shares of 54.8M outstanding shares and own 24.67% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (2.25M shares), Chescapmanager LLC (1.7M shares), FARALLON CAPITAL MANAGEMENT LLC (1.56M shares), DISCIPLINED GROWTH INVESTORS INC /MN (1.11M shares), RENAISSANCE TECHNOLOGIES LLC (1.11M shares), TWO SIGMA ADVISERS, LP (866K shares), BlackRock, Inc. (742K shares), MILLENNIUM MANAGEMENT LLC (588K shares), BNP PARIBAS FINANCIAL MARKETS (583K shares), and GEODE CAPITAL MANAGEMENT, LLC (452K shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.